London · Delayed Price · Currency is GBP · Price in GBX Porvair Earnings Call Transcripts
Fiscal Year 2026
-
Record revenue and profit growth driven by strong aerospace, aluminum, and life sciences demand, with three strategic acquisitions enhancing each division. Despite subdued petrochemical markets, margins and cash generation remain robust, supporting continued investment and unchanged full-year guidance.
Fiscal Year 2025
-
Record revenue and profit with margin improvement, driven by strong performance in laboratory and aluminum filtration markets. Acquisition of Drache expands global reach, while robust cash generation supports ongoing investment and dividend growth.
-
Revenue and adjusted EPS grew 3% year-over-year, with strong cash generation and a net cash position of £17.1 million. Segment performance was mixed, with robust growth in petrochem and laboratory instruments offsetting weaker U.S. industrials and aerospace.
Fiscal Year 2024
-
Record revenue and profit growth driven by strong Aerospace and Industrial performance, resilient margins, and a robust net cash position. Near-term volatility and economic uncertainty persist, but long-term growth drivers and strategic outlook remain unchanged.
-
Revenue grew 5% year-over-year, with strong aerospace and petrochemical performance offsetting weakness in consumables and metal melt. Operating profit rose 2%, and the interim dividend increased by 5%. Outlook for the second half and 2025 remains positive, with major CapEx planned.